All companies
Visit website
Quim
OperatingQuim Rock, Inc.
Healthcare · Founded 2016
Woman-founded
Plant-based intimate wellness products, designed with your needs in mind.
Valuation cap ⓘ
$10.0M
As of Jan 2021 · from Quim SAFE 1 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$318,289
Across 1 round since 2020
Latest share price
$1.00
Quim SAFE 1 offering price
Financials
FY2018–FY2023 · from SEC filings · hover any figure for its source$13K
−$131K
2018
$201K
−$178K
2019
$33K
−$217K
2020
$117K
−$86K
2021
$113K
−$264K
2022
$45K
−$23K
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
Income statement
Revenue
$12,669
$201,219
$32,579
$116,601
$113,159
$45,235
Cost of goods sold
$30,422
$181,341
$94,098
$113,246
$277,351
$17,894
Gross margin
-140%
10%
-189%
3%
-145%
60%
Net income
-$131,256
-$178,165
-$216,529
-$86,011
-$263,882
-$23,477
Taxes paid
$0
$0
$0
$0
$0
$0
Balance sheet
Cash
$242,462
$193,504
$20,401
$141,964
$14,914
$120,536
Accounts receivable
$303
$16,270
$0
$16,546
$0
$11,449
Total assets
$433,503
$578,879
$558,276
$695,397
$515,573
$488,486
Short-term debt
$60,247
$6,286
$920,018
$1,227,190
$1,277,313
$1,273,703
Long-term debt
$0
$0
$129,566
$139,566
$164,566
$164,566
Total liabilities
$60,247
$6,286
$1,049,584
$1,366,756
$1,441,879
$1,438,269
Other
Headcount
—
3
3
3
—
0
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$10.0M
Valuation cap
Quim SAFE 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $318.3K / $1.1MInvestors 673Valuation cap $10M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 4 of 6 annual reports (FY2020–FY2025)
673 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 9 filings on EDGARSource: ManualCIK 0001821386Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.